Cytek Biosciences CTKB Stock
Cytek Biosciences Price Chart
Cytek Biosciences CTKB Financial and Trading Overview
Cytek Biosciences stock price | 3.63 USD |
Previous Close | 8.38 USD |
Open | 8.32 USD |
Bid | 0 USD x 900 |
Ask | 0 USD x 800 |
Day's Range | 8.32 - 8.74 USD |
52 Week Range | 6.45 - 16.05 USD |
Volume | 919.76K USD |
Avg. Volume | 1.36M USD |
Market Cap | 1.18B USD |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.05 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 14.25 USD |
CTKB Valuation Measures
Enterprise Value | 855.15M USD |
Trailing P/E | N/A |
Forward P/E | 28 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 7.09135 |
Price/Book (mrq) | 2.7802691 |
Enterprise Value/Revenue | 5.15 |
Enterprise Value/EBITDA | -115.405 |
Trading Information
Cytek Biosciences Stock Price History
Beta (5Y Monthly) | N/A |
52-Week Change | -12.58% |
S&P500 52-Week Change | 20.43% |
52 Week High | 16.05 USD |
52 Week Low | 6.45 USD |
50-Day Moving Average | 9.13 USD |
200-Day Moving Average | 11.45 USD |
CTKB Share Statistics
Avg. Volume (3 month) | 1.36M USD |
Avg. Daily Volume (10-Days) | 721.54K USD |
Shares Outstanding | 135.67M |
Float | 91.5M |
Short Ratio | 5.47 |
% Held by Insiders | 17.06% |
% Held by Institutions | 55.10% |
Shares Short | 8.68M |
Short % of Float | 7.24% |
Short % of Shares Outstanding | 6.40% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -1.44% |
Operating Margin (ttm) | -6.087% |
Gross Margin | 61.32% |
EBITDA Margin | -4.46% |
Management Effectiveness
Return on Assets (ttm) | -1.25% |
Return on Equity (ttm) | -0.52% |
Income Statement
Revenue (ttm) | 166.06M USD |
Revenue Per Share (ttm) | 1.23 USD |
Quarterly Revenue Growth (yoy) | 5.80% |
Gross Profit (ttm) | 100.97M USD |
EBITDA | -7410000 USD |
Net Income Avi to Common (ttm) | -2394000 USD |
Diluted EPS (ttm) | -0.01 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 299M USD |
Total Cash Per Share (mrq) | 2.2 USD |
Total Debt (mrq) | 17.26M USD |
Total Debt/Equity (mrq) | 4.08 USD |
Current Ratio (mrq) | 7.531 |
Book Value Per Share (mrq) | 3.122 |
Cash Flow Statement
Operating Cash Flow (ttm) | -7893000 USD |
Levered Free Cash Flow (ttm) | -31802124 USD |
Profile of Cytek Biosciences
Country | United States |
State | CA |
City | Fremont |
Address | 47215 Lakeview Boulevard |
ZIP | 94538 |
Phone | 877 922 9835 |
Website | https://cytekbio.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 682 |
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Q&A For Cytek Biosciences Stock
What is a current CTKB stock price?
Cytek Biosciences CTKB stock price today per share is 3.63 USD.
How to purchase Cytek Biosciences stock?
You can buy CTKB shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cytek Biosciences?
The stock symbol or ticker of Cytek Biosciences is CTKB.
Which industry does the Cytek Biosciences company belong to?
The Cytek Biosciences industry is Medical Devices.
How many shares does Cytek Biosciences have in circulation?
The max supply of Cytek Biosciences shares is 128.1M.
What is Cytek Biosciences Price to Earnings Ratio (PE Ratio)?
Cytek Biosciences PE Ratio is now.
What was Cytek Biosciences earnings per share over the trailing 12 months (TTM)?
Cytek Biosciences EPS is -0.05 USD over the trailing 12 months.
Which sector does the Cytek Biosciences company belong to?
The Cytek Biosciences sector is Healthcare.
Cytek Biosciences CTKB included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 16283.51 USD — |
-3.21
|
4.37B USD — | 16283.1 USD — | 16600.37 USD — | — - | 4.37B USD — |
Nasdaq US 700 Small Cap Index NQUS700SC | 1956.38 USD — |
-1.44
|
— — | 1950.84 USD — | 1985.27 USD — | — - | — — |
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2626 USD — |
-1.59
|
— — | 2619.66 USD — | 2665.89 USD — | — - | — — |
NASDAQ HealthCare IXHC | 882.26 USD — |
-1.79
|
— — | 880.7 USD — | 895.82 USD — | — - | — — |
NASDAQ Global Select Market Com NQGS | 7941.9 USD — |
-3.5
|
— — | 7927.62 USD — | 8119.29 USD — | — - | — — |
- {{ link.label }} {{link}}